Ocular Therapeutix reported a net loss of $13.8 million, or $0.37 per share, in the second quarter of 2018 compared with a net loss of $18.7 million, or $0.64 per share, in the same time period of 2017.
Revenues were attributed to sales of ReSure sealant and totaled $0.6 million compared with $0.4 million a year ago, according to a company press release.
General and administrative costs for the quarter increased from $3.7 million in 2017 to $4.4 million in 2018, which was attributed to an increase in legal costs (Read more...)
Uncategorized